1.11037

tri-Sodium citrate

anhydrous, EMPROVE^® ESSENTIAL, USP, FCC, E 331

• Synonim(y): tri-Sodium citrate
• Wzór empiryczny (zapis Hilla): C₆H₅Na₃O₇
• Numer CAS: 68-04-2
• Masa cząsteczkowa: 258.07
• Numer MDL: MFCD00012462
• Kod UNSPSC: 12352107
• Numer E: E331
• Numer indeksu EC: 200-675-3

Właściwości

• agency: USP
• Poziom jakości: 500
• zgodność regionalna: FCC
• linia produktu: EMPROVE^® ESSENTIAL
• Postać: solid
• pH: 7.5-9.0 (20 °C, 10 g/L in H₂O)
• mp: 150 °C (decomposition)
• rozpuszczalność: 425 g/L
• gęstość: 1.76 g/cm³ at 18 °C
• Zastosowanie: liquid formulation; ophthalmics; pharmaceutical; semi-solid formulation; solid formulation
• temp. przechowywania: 2-30°C
• InChI: 1S/C6H8O7.3Na/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3
• Klucz InChI: HRXKRNGNAMMEHJ-UHFFFAOYSA-K

Opis

Opis ogólny

Finding the right excipient that matches your needs as well as regulatory demands can be a complicated challenge. With our application know-how and regulatory expertise, we support you in every step of development, scale-up, and production.
As part of our Emprove^® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC^® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Zastosowanie

tri-Sodium citrate anhydrous is typically used as a citrate buffer system component for biomolecule downstream chromatography steps or final liquid formulation.

Informacje prawne

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 1